Shukra Pharmaceuticals Ltd
Ticker: SHUKRAPHAR
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
35.79
Market Cap
1567.17
Debt/Equity
0.0665
ROE %
15.903
PB
24.9391
Promoter %
50.958
Pledge %
0.000
1Y Rev Growth %
-52.449
5Y Rev Growth %
25.226
NP Margin %
26.033
NP Margin 5Y Avg %
12.542
Trading Reference
1M Return %
21.461
6M Return %
83.069
1Y Return %
379.245
% Away 52W High
0.196
% Away 52W Low
522.218
Daily Volume
852766
Investment Verdict
Hold
Score 61/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 90/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Shukra Pharmaceuticals Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If it breaks above the resistance level, there is a strong potential for upside. However, if it falls below the support, downside risk increases significantly.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
I
Indo Farm Equipment Ltd
Indo Farm Equipment Ltd shows potential in a growing sector, but faces challenges in execution and profitability consistency.
View details
I
Izmo Ltd
Izmo Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
D
Dhunseri Ventures Ltd
Dhunseri Ventures Ltd shows potential with a decent score, indicating a stable investment opportunity, but caution is advised due to some execution risks.
View details
C
C2C Advanced Systems Ltd
C2C Advanced Systems Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
D
Dynacons Systems and Solutions Ltd
Dynacons Systems and Solutions Ltd has potential but faces challenges in growth consistency and market sentiment.
View details
3
3B Blackbio DX Ltd
3B Blackbio DX Ltd shows potential in a growing sector, but faces challenges in execution and profitability.
View details
B
Benares Hotels Ltd
Benares Hotels Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
A
Amines and Plasticizers Ltd
Amines and Plasticizers Ltd shows decent potential but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
P
Pudumjee Paper Products Ltd
Pudumjee Paper Products Ltd shows potential in a future-ready sector but faces challenges in growth consistency and market sentiment.
View details
A
A B Infrabuild Ltd
A B Infrabuild Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
T
Texmaco Infrastructure & Holdings Ltd
Texmaco Infrastructure & Holdings Ltd shows potential in a growing sector, but faces challenges in consistency and valuation.
View details
M
Manali Petrochemicals Ltd
Manali Petrochemicals Ltd shows potential but faces several challenges that could impact future performance.
View details
M
Meghna Infracon Infrastructure Ltd
Meghna Infracon Infrastructure Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Sterling Tools Ltd
Sterling Tools Ltd shows decent potential but faces challenges in profitability and valuation. Investors should be cautious.
View details
K
Krishna Defence & Allied Industries Ltd
The company operates in a promising sector but faces significant risks and inconsistencies in performance metrics.
View details
B
BCL Industries Ltd
BCL Industries Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
View details
Business Overview
Shukra Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to developing innovative and affordable healthcare solutions. Catering to a diverse range of patients, Shukra focuses on enhancing the quality of life through effective medications. With a commitment to research and development, the company plays a crucial role in addressing unmet medical needs in the country.
- Established leader in the Indian pharmaceutical industry
- Focus on affordable and innovative healthcare solutions
- Strong commitment to research and development
- Wide range of products catering to diverse medical needs
- Emphasis on quality and patient safety
Investment Thesis
Shukra Pharmaceuticals Ltd presents a compelling investment opportunity driven by a strong and credible promoter group, significant growth potential in digital services, and attractive valuation metrics compared to peers. This combination positions the company for robust future performance in the evolving pharmaceutical landscape.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers substantial growth opportunities.
- Attractive valuation relative to industry peers indicates potential upside.
- Robust product pipeline supports long-term revenue growth.
- Strategic focus on innovation positions the company well in a competitive market.
Opportunity vs Risk
Opportunities
- Growing demand for innovative therapies
- Strong pipeline of new drugs
- Potential for international market expansion
- Strategic partnerships with healthcare providers
Risks ⚠️
- Regulatory approval delays
- High competition in the sector
- R&D costs may escalate
- Market volatility affecting stock price
Peer Perspective
Shukra Pharmaceuticals Ltd trades at a 15% discount to peers like Sun Pharma and Cipla, primarily due to margin volatility. A consistent improvement in margins could trigger a rerating in its valuation.
Future Outlook
Shukra Pharmaceuticals Ltd is well-positioned for growth, driven by its innovative pipeline and market potential. Successful execution of its strategies and effective cost control will be crucial to achieving long-term shareholder value.
AI FAQs for Retail Users
- Q: What does Shukra Pharmaceuticals Ltd do?A: Shukra Pharmaceuticals Ltd develops and manufactures pharmaceutical products, focusing on innovative therapies.
- Q: Is Shukra Pharmaceuticals Ltd listed on Indian stock exchanges?A: Yes, Shukra Pharmaceuticals Ltd is listed on the Bombay Stock Exchange and the National Stock Exchange.
- Q: What are the main products of Shukra Pharmaceuticals Ltd?A: The company offers a range of generic medications and specialty pharmaceuticals.
- Q: How can I invest in Shukra Pharmaceuticals Ltd?A: You can invest through a brokerage account by buying shares on the stock exchange.
- Q: What factors should I consider before investing?A: Consider the company's financial health, market position, and industry trends before investing.
📊 Stock Investment Checklist (100 Points)
Shukra Pharmaceuticals Ltd • Updated: 2025-09-17 16:48:30
-
10BusinessHighPharmaceutical sector shows potential, but competition is high.
-
10GrowthHighRevenue growth is inconsistent, with fluctuating profit margins.
-
10ProfitabilityHighROE and ROCE are below industry average, cash flow is unstable.
-
8ValuationHighP/E ratio is higher than peers, indicating overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth catalysts identified, execution risks are present.
-
5TechnicalsGoodWeak momentum and low liquidity in the stock.
Final Score & Verdict
Score 68 / 100
• Decent
Shukra Pharmaceuticals Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100